×

Yemen cholera outbreak claims one life every hour

The rising number of suspected cases of cholera resulting from a severe outbreak in Yemen has passed 100,000, the World Health Organization (WHO) reports.

Cholera is affecting the most vulnerable. Children under the age of 15 years account for 46 per cent of cases, and those aged over 60 years represent 33 per cent of fatalities.

Cholera, an acute enteric infection, is caused by the ingestion of food or water contaminated with the bacterium Vibrio cholera. It can kill children within just a few hours. Cholera should be an easily treatable disease when there is access to functioning medical services. 

WHO believes that cholera is primarily linked to insufficient access to safe water and proper sanitation and its impact can be even more dramatic in areas where basic environmental infrastructures are disrupted or have been destroyed.

Humanitarian partners have been responding to the cholera outbreak since October 2016.  However, Yemen’s health, water and sanitation systems are collapsing after two years of war. The risk of the epidemic spreading further and affecting thousands more is real as the water hygiene systems are unable to cope.

The UN Office for the Co-ordinatior of Humanitarian Affairs (OCHA) Jamie McGoldrick said the fast spreading epidemic in Yemen was “of an unprecedented scale”.

Mr Goldrick also fears that hundreds of thousands of people are at a greater risk of dying as they face the “triple threat” of conflict, starvation and cholera. He believes the cause is clear.

“Malnutrition and cholera are interconnected; weakened and hungry people are more likely to contract cholera and cholera is more likely to flourish in places where malnutrition exists,” Mr Goldrick said. 

More than half of Yemen’s health facilities are no longer functioning, with almost 300 having been damaged or destroyed in the fighting.

Systems that are central to help treat and prevent outbreaks of the disease have failing in Yemen. Fifty per cent of medical facilities no longer function. Some have been bombed and others have ground to a halt because there is no funding.

The International Committee of the Red Cross (ICRC) Director of Operations Dominik Stillhart said: “Hospitals are understaffed and cannot accommodate the influx of patients – with up to four people seeking treatment per bed. There are people in the garden, and some even in their cars with the IV drip hanging from the window.”

Local health workers, including doctors and nurses have not been paid for eight months; only 30 per cent of required medical supplies are being imported into the country; rubbish collection in the cities is irregular; and more than eight million people lack access to safe drinking water and proper sanitation.

UNICEF is reported to have flown in over 40 tonnes of medicines, rehydration salts, intravenous fluids and other life-saving supplies to treat approximately 50,000 patients in Yemen.

Meredith Horne

[Comment] A global research agenda on migration, mobility, and health

With 1 billion people on the move globally—more than 244 million of whom have crossed international borders1—and a recognised need to strengthen efforts towards universal health coverage,2 developing a better understanding of how to respond to the complex interactions between migration, mobility, and health is vital. At the 2nd Global Consultation on Migrant Health in Sri Lanka earlier this year, a group of global experts in health and migration discussed the progress and shortfalls in attaining the actions set out in the 2008 World Health Assembly (WHA) Resolution on the Health of Migrants.

Air pollution linked with heart damage

A new report presented by the European Society of Cardiology says that there is strong evidence that particulate matter (PM) emitted mainly from diesel road vehicles is associated with increased risk of heart attack, heart failure, and death.

The lead author Dr Nay Aung, a cardiologist and Wellcome Trust research fellow at the William Harvey Research Institute, Queen Mary University of London, UK, said the cause for the heart damage “appears to be driven by an inflammatory response – inhalation of fine particulate matter (PM2.5) causes localised inflammation of the lungs followed by a more systemic inflammation affecting the whole body.”

Regarding how pollution might have these negative effects on the heart, Dr Aung said PM2.5 causes systemic inflammation, vasoconstriction and raised blood pressure. The combination of these factors can increase the pressure in the heart, which enlarges to cope with the overload. The heart chamber enlargement reduces the contractile efficiency leading to reduction in ejection fraction.

The researchers said they found evidence of harmful effects even when levels of pollution associated with diesel vehicles were less than half the safety limit set by the European Union.

Dr Aung said: “We found that the average exposure to PM2.5 in the UK is about 10 µg/m3 in our study. This is way below the European target of less than 25 µg/m3 and yet we are still seeing these harmful effects. This suggests that the current target level is not safe and should be lowered.”

In the UK, where the study was conducted, the Government recently produced its third attempt at a plan to bring air pollution to within levels considered safe under European Union legislation after judges ruled the previous versions were not effective enough to comply with the law.

Dr Penny Woods, chief executive of the British Lung Foundation, said: “Air pollution (in the UK) is a public health crisis hitting our most vulnerable the hardest – our children, people with a lung condition and the elderly.” 

Dr Woods added that, while progress was being made in high-income countries to reduce deaths from cardiovascular disease and cancer, those caused by lung disease had “remained tragically constant”. 

The World Health Organisation (WHO) estimates that some 3 million deaths a year are linked to exposure to outdoor air pollution. WHO also believes that indoor air pollution can be just as deadly. In 2012, an estimated 6.5 million deaths (11.6 per cent of all global deaths) were associated with indoor and outdoor air pollution together.

Only one in ten people breathe safe air according to WHO guidelines and over 80 per cent of the world’s cities have air pollution levels over what these guidelines deem safe.

The Australian Medical Association has developed a Position Statement on Climate Change and Human Health that acknowledges air pollution is the world’s single largest environmental health risk.

Meredith Horne

Germany set to introduce fines of up to €2,500 for failing to vaccinate

A new German law will be introduced obliging kindergartens to inform the authorities if parents fail to provide evidence that they have received advice from their doctor on vaccinating their children.

Parents refusing the advice risk fines of up to 2,500 euros under the law expected to come into force in June this year.

Health Minister Hermann Gröhe said it was necessary to tighten the law because of a measles epidemic.

Germany has reported 410 measles cases so far this year, more than in the whole of 2016. A 37-year-old woman died of the disease this May, in the western city of Essen.

The German government wants kindergartens to report any parents who cannot prove they have had a medical consultation.

However, Germany is not yet making it an offence to refuse vaccinations. The children of parents who fail to seek vaccination advice could be expelled from their daycare centre.

Vaccination rules are being tightened across Europe, where a decline in immunisation, has caused a spike in diseases such as measles, chicken pox and mumps, according to the European Centre for Disease Prevention and Control (ECDC).

Italy made vaccination compulsory in May this year, after health officials warned that a fall-off in vaccination rates had triggered a measles epidemic, with more than 2,000 cases there this year, almost ten times the number in 2015.

In 10 European countries, cases of measles, which can cause blindness and encephalitis, had doubled in number in the first two months of 2017 compared to the previous year, the ECDC said last month.

Measles is a highly infectious vaccine-preventable disease, and globally still one of the leading causes of childhood mortality.

The World Health Organisation reports that the European Region includes highly effective and safe measles and rubella vaccines in their vaccination programs; however, due to persistent gaps in immunisation coverage outbreaks of measles and rubella continue to occur. 

The Australian Medical Association endorses the overwhelming scientific evidence that vaccination saves lives. Important immunisation information is available in the Australian Academy of Science publication, The Science of Immunisation: Questions and Answers, which is available at www.science.org.au/immunisation.html .

Meredith Horne

World leading Australian scientists developing nuclear medicine to save lives

The Australian Nuclear Science and Technology Organisation (ANSTO), has signed an MOU with the Sri Lankan Presidential Taskforce for Prevention of Chronic Kidney Disease to assist in the fight against Chronic Kidney Disease of Unknown Etiology (CKDu).

Sri Lanka’s High Commissioner to Australia, H.E. Somasundaram Skandakumar, and the CEO of ANSTO, Dr Adi Paterson, signed an MOU that will see Australia provide new insights into the disease. 

“ANSTO’s expertise is in nuclear science, applied science and management of landmark infrastructure, and this new agreement is an opportunity to bring together all three, and to work on identifying the possible causes and treatments,” said Dr Paterson.

CKDu is a major health problem in Sri Lanka affecting more than 15 per cent of the population aged 15-70 years in the North Central Province, mostly poor farmers living in remote areas.  According to the World Health Organization (WHO), the disease is now also prevalent in the North western, Eastern, Southern and Central provinces.

The true number of CKDu cases and the cause of the disease remain unknown. CKDu is a progressive condition marked by the gradual loss of kidney function. There is an increasingly urgent need to identify the cause of CKDu in order to prevent and treat the disease and save vulnerable lives.

Priorities for addressing CKDu include earlier diagnosis and improved working conditions in such intense heat. Initial symptoms of the disease are nondistinct, such as tiredness and appetite loss, meaning people are usually diagnosed late, when damage to the kidney is extensive and irreversible. The only option at this stage is dialysis, which is not always available or accessible.

It is also a serious public health problem in other countries, particularly in Central America, and despite more than 20 years of study in Sri Lanka and globally, it is not well understood.  While CKDu appears to disproportionally affect poor, rural, male farmers in hot climates, the reasons why are not yet clear.

The World Health Organisation has identified several potential contributing factors, including heavy metals in the groundwater, agrochemicals, heat stress, malnutrition and low birth weight, and leptospirosis.

ANSTO and Australia will bring together several types of science and science infrastructure, including the ANSTO operated Synchrotron, as part of the research effort to investigate the epidemiology of CKDu.

ANSTO has capabilities to investigate a number of the possible causes, routes of distribution and treatments, particularly in relation to studying any causal links with heavy metals in water, or agrochemicals.

Meredith Horne

Towards tobacco free investment

 The AMA Council of Doctors in Training (AMACDT) was delighted to have Dr Bronwyn King, Founder and Chief Executive Officer, Tobacco Free Portfolios, share her insights on leadership and advocacy at the AMA Leadership Development Dinner on 26 May 2017 at Eureka 89 in Melbourne.

Dr King was the keynote speaker at this event and spoke passionately about her experience working towards tobacco control that has led to a significant global shift towards tobacco-free investment.

A Radiation Oncologist, Dr King explained how she found out by accident that her Super Fund was investing her money in tobacco companies – the very companies that made the products which caused unimaginable harm to her patients!

Since then, Dr King has led the charge to persuade superannuation funds to exclude tobacco companies from their portfolios. 35 large Australian Super Funds are now tobacco-free, having divested approximately $2.5 billion worth of tobacco stocks.

There are many alarming statistics relating to tobacco:

–          15,000 Australians die early as a result of tobacco every year;

–          In 2016, more Australian women died from lung cancer from breast cancer; and

–          The World Health Organisation estimates that the world is on track for one billion tobacco-related deaths this century.

The problem is that most people don’t know whether their money is being invested in tobacco or not.

Tobacco Free Portfolio’s newest initiative, Verified Tobacco-Free, aims to solve this problem.  

The team at Tobacco Free Portfolios have designed the Verified Tobacco-Free logo which will be available for adoption by Super Funds with tobacco-free investment policies, subject to an audit to confirm their tobacco-free status.

The Verified Tobacco-Free logo will help consumers to make easy, informed decisions in relation to their superannuation investment.

–          Super Funds can proudly display the logo to clearly demonstrate their tobacco-free status.

–          Fund members can be sure that their money is not being invested in tobacco.

–          Verified Tobacco-Free Super Funds can be ‘named and famed’, which will encourage other funds to follow suit.

A crowdfunding campaign is currently underway to support the initiative. Dr King aims to raise over $50,000 to make the Verified Tobacco Free initiative a reality. You can support Dr King’s work by going to https://pozible.com/project/verified-tobacco-free

Dr John Zorbas, AMACDT Chair, praised Dr King’s resolve and initiative and said her address had inspired all who attended to have the courage to lead and advocate for what they knew was morally and ethically right and in the best interests of patient care and the health of the wider community.

“In particular Dr King emphasised the value of having in place a strong network made up of family and friends to support you and help you to maintain a work life balance that’s right for you. As a leader it’s vitally important to recognise your own health needs and enlist support from those around you if you are to achieve your goals and continue to function effectively and efficiently.”

The Leadership Development Dinner is held every year as part of AMA National Conference. This year over seventy doctors in training, medical students, consultants and international guests attended the event which is widely acknowledged as one of the most important events of its type, providing future healthcare leaders with an opportunity to gain new insights into effective leadership.

In 2018, the AMA Leadership Development Dinner will be held on May 25 at the National Portrait Gallery in Canberra.

Sally Cross
Senior Policy Adviser, AMA

 

The benefits of international health experiences for Australian and New Zealand medical education

Embracing structured international health experiences in mainstream medical education is critical to the development of future doctors

Globalisation has dramatically changed and continues to change the way the world works. Societies, businesses and individuals are increasingly adapting to a world with fewer borders and geographical constraints than in the past.1 Global health has been defined as:

an area for study, research and practice that places a priority on improving health and achieving health equity for all people worldwide, [which] emphasises transnational health issues, determinants and solutions; involves many disciplines between and beyond the health sciences; and synthesises population-based prevention with individual-level care.2

Despite the emergence and establishment of global health as an academic discipline, it largely resides within public health education and practice, and is typically taught and learnt within Master of Public Health programs, rather than through experiences within mainstream medical education. In Australian and New Zealand medical programs, clinical learning with a global health focus is generally achieved through the inclusion of clinical placement electives that permit student-initiated and organised international health experiences (IHEs).2 In cases where the IHEs are arranged by the university, they are generally short and optional.

Market forces and increasing demand for international health experiences

Clinical learning beyond a medical student’s home university is a relatively new phenomenon, but IHEs have expanded dramatically over the past 30 years. In the United States, the proportion of graduating medical students who completed a clinical learning experience abroad was only 6% in 1978, but has risen progressively to 22% in 2004, and 31% in 2010.3,4 Estimates for the United Kingdom indicate that 90% of medical students undertake IHEs, with 44% doing these in developing countries.5 In Australia, the Medical Schools Outcomes Database shows that half of Australian medical students undertook an IHE elective between 2006 and 2010. Of those, the majority (59%) did so in lower or middle income countries.6

When combined with the growth of medical enrolments over the past decade,7 the actual number of Australian and New Zealand medical students undertaking clinical learning in international settings is significant. Interestingly, this rapid increase in global clinical learning has been driven almost entirely by student demand and has been predominantly organised by students.2,3

The value proposition of global experiences

A recent report commissioned by Universities Australia8 highlighted the benefits of global experiences to students in a range of disciplines, and to the nation. These include promoting deep learning and cognitive development in relation to cultural differences; and encouraging civic engagement, including increased understanding of moral and ethical issues, openness to diversity, more positive perceptions of multiculturalism, and greater levels of tolerance and the reduction of ethnocentrism. These are qualities that, if held by future medical graduates, will promote the health of the multicultural Australian community and the broader global community.

In medicine specifically, there is consistent evidence for the educational and personal benefits of IHEs in both pre-certification and early post-practice settings, as well as their broader value for the health care system. A number of qualitative and quantitative evaluations, including those comparing medical students who have undertaken IHEs with those who have not, have shown the positive impact of IHEs on personal consultation, clinical and diagnostic skills;3,9,10 significantly higher average scores in the preventive medicine and public health portions of the National Board of Medical Examiners assessments;11 and a greater appreciation of the importance of public health, health service delivery and cross-cultural communication.3,912 Further, an increased appreciation of the role of primary care and the importance of addressing the unmet needs of under-served communities is demonstrated by the career destinations of these graduates.3,10

Many global student experiences take place between two developed countries. While these IHEs have advantages in terms of risk minimisation for students, they can limit the potential benefits that might present with experiences in developing countries. A frequent theme that emerges from evaluations is the way in which IHEs can facilitate a personal transformation in medical students’ attitudes and cultural sensitivities.3 Jacobs and colleagues emphasised the value of students experiencing cultures, health systems and learning environments different from their own when they undertake an IHE, and being able to compare different health systems and cultures in such transformative learning. They noted that the “perception of differences between the cultures resulted in a rethinking of the participants’ own views, attitudes, and actions”.12 Experiences where students undertake electives in developing countries provide this opportunity for greater comparative learning, because of the stark differences in case mix, culture and health systems between developed and developing countries. However, associated risk factors and perceived “voluntourism” raise concerns for medical schools.2 Although understandable, a focus on risk instead of opportunity has the potential to limit what could be achieved through a more open approach to medical education that embraces global health experiences. Such an approach can lead to stronger graduate outcomes, especially in the domains of citizenship and professionalism, and to positive impacts on patient outcomes and the health care systems in the host and home countries.3,8,11

Medical schools’ responsibilities in international health electives

The involvement of Australian and New Zealand medical schools in quality assuring IHEs is critical, especially in an environment where the student demand to undertake global clinical experiences is rising. Medical schools are required by the Australian Medical Council to provide “opportunities for students to pursue studies of choice that promote breadth and diversity of experience”.13 Medical schools largely address this requirement by including an elective term within the clinical placement component of their programs. In the US, the equivalent accrediting body has recently mandated pre-departure training for IHEs for accredited medical schools.14

Australia’s Tertiary Education Quality and Standards Agency (TEQSA) has a strong quality framework concerning domestic student study abroad, designed to “assure that a provider’s responsibilities under the TEQSA Act and the Higher Education Framework are upheld and maintained where the provider is involved in offshore higher education provision”.15 This responsibility includes the quality assurance of student support and course delivery, and the equivalence of student learning outcomes. By virtue of the tendency to frame IHEs within electives, the quality assurance of learning and assessment, and the assessment of the adequacy of such experiences by accrediting bodies, may not be as robust as other more formalised clinical placement experiences. Is it time for medical schools to consider the purposeful creation and inclusion of more structured, quality assured and, where possible, longitudinal global health experiences within their medical programs? This would best be achieved through the establishment of strong and mutually beneficial partnerships with international organisations, universities and health care providers.9 Further, a set of rigorous academic standards and clearly stated outcomes that respond to clinical needs and students’ desired developmental goals should be developed to ensure the implementation of evaluation, review and improvement cycles.

Conclusion

Medical education is not immune to globalisation. The strong demand from Australian students for global clinical learning, and their mobilisation to deliver opportunities that meet this demand, including the creation of student international health organisations,16 indicate the value that students place on IHEs. There is demonstrable educational value in clinical learning abroad, and it is timely for medical schools and accrediting bodies to advance the study of global health beyond Master of Public Health programs by integrating IHEs into existing medical curricula.

[Correspondence] Sania Nishtar is the health leader that the world needs

Dr Sania Nishtar is the ideal person to lead WHO and we urge the world’s 194 health ministers to elect her as the next Director–General (DG) in the coming World Health Assembly. Every health minister at the World Health Assembly will be aware of the wide and deep challenges facing WHO and global public health, and will be cognisant of the need to find the best leader. This is not a claim we make lightly. Many of the arguments for our claim are set out in detail in Nishtar’s published manifesto,1 but some of the more important points bear repeating.

[Correspondence] Open letter urges WHO to take action on industrial animal farming

Margaret Chan, the Director-General of WHO, spoke at last year’s World Health Assembly (WHA) to call for action from the international community on three “slow motion disasters” that she expected would soon “reach a tipping point where the harm done is irreversible.”1 These issues are climate change, antibiotic resistance, and the rise of non-communicable diseases. The election of a new Director-General at WHO this May brings an opportunity to set a new agenda. WHO has already taken leadership on the crises outlined by Chan, especially on antibiotic resistance.

[Correspondence] Dr Tedros Adhanom Ghebreyesus is the best candidate for WHO DG

As Sally Davies has already pointed out,1 the World Health Assembly will shortly meet to elect the next Director-General (DG) of WHO. Three candidates (Tedros Adhanom Ghebreyesus [Ethiopia], Sania Nishtar [Pakistan], and David Nabarro [UK]) were selected by the WHO Executive Board in January, 2017, for the final stage of the election. All three are well qualified and experienced in their own ways and all fulfil WHO’s established criteria.1 So the important issue for the world’s ministers of health, meeting in Geneva, Switzerland, will be deciding which of the three candidates could best lead the needed reforms at WHO while also protecting and enhancing the health of the world’s people.